Trial Profile
A retrospective study to evaluate dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Dexrazoxane (Primary) ; Anthracyclines
- Indications Cancer
- Focus Therapeutic Use
- 25 Nov 2015 New trial record